G&S Capital’s HCA Healthcare HCA Stock Holding History

G&S Capital’s Portfolio HCA Stock Details HCA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-567	Closed	-$74K	–	227
2019 Q1	$74K	Buy	567 +73	+15%	+$9.8K	0.05%	111
2018 Q4	$61K	Buy	+494	New	+$66.3K	0.06%	93

Other funds holding HCA

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

MAM

Magellan Asset Management Sydney, Australia $7.71B AUM 11.08% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

AAMU

Amundi Asset Management US Boston, Massachusetts $131B AUM 73.57% 1-Year Est. Return

Longview Partners St Peter Port, Guernsey $7.06B AUM 3.43% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Harris Associates Chicago, Illinois $75B AUM 11.27% 1-Year Est. Return

G&S Capital's HCA Position: Q2 2019 in Review

G&S Capital sold out of HCA Healthcare (HCA) in Q2 2019, closing a stake of 567 shares — an estimated $74K sold.

G&S Capital first reported a position in HCA in Q4 2018 and held it in 2 quarters. The position peaked at $74K in Q1 2019. 675 funds tracked by Wall St. Rank hold HCA as of Q2 2019.

G&S Capital reported no remaining HCA Healthcare position as of Q2 2019 after selling out during the quarter.
G&S Capital sold 567 HCA Healthcare shares in Q2 2019, an estimated $74K.
G&S Capital first reported a position in HCA Healthcare in Q4 2018 and held it in 2 quarters.
G&S Capital's HCA Healthcare position peaked at $74K in Q1 2019.
675 funds tracked by Wall St. Rank held HCA Healthcare as of Q2 2019.

Based on G&S Capital's 13F filing for Q2 2019, filed 19 Jul 2019.